| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | proteasome-activating activity | 9.53e-05 | 6 | 51 | 2 | GO:0036402 | |
| GeneOntologyCellularComponent | P-body | 1.12e-04 | 102 | 51 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | proteasome regulatory particle, base subcomplex | 3.79e-04 | 12 | 51 | 2 | GO:0008540 | |
| Domain | Actinin_actin-bd_CS | 3.08e-05 | 23 | 50 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 3.08e-05 | 23 | 50 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.08e-05 | 23 | 50 | 3 | PS00019 | |
| Domain | 26S_Psome_P45 | 1.05e-04 | 6 | 50 | 2 | IPR005937 | |
| Domain | - | 1.05e-04 | 6 | 50 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 1.05e-04 | 6 | 50 | 2 | PF00930 | |
| Domain | Peptidase_S9B_N | 1.05e-04 | 6 | 50 | 2 | IPR002469 | |
| Domain | IG_FLMN | 3.12e-04 | 10 | 50 | 2 | SM00557 | |
| Domain | Filamin | 3.80e-04 | 11 | 50 | 2 | PF00630 | |
| Domain | Filamin/ABP280_rpt | 3.80e-04 | 11 | 50 | 2 | IPR001298 | |
| Domain | Peptidase_S9 | 3.80e-04 | 11 | 50 | 2 | PF00326 | |
| Domain | Filamin/ABP280_repeat-like | 3.80e-04 | 11 | 50 | 2 | IPR017868 | |
| Domain | Peptidase_S9 | 3.80e-04 | 11 | 50 | 2 | IPR001375 | |
| Domain | FILAMIN_REPEAT | 3.80e-04 | 11 | 50 | 2 | PS50194 | |
| Domain | CH | 7.02e-04 | 65 | 50 | 3 | SM00033 | |
| Domain | CH | 8.71e-04 | 70 | 50 | 3 | PF00307 | |
| Domain | - | 9.08e-04 | 71 | 50 | 3 | 1.10.418.10 | |
| Domain | CH | 9.84e-04 | 73 | 50 | 3 | PS50021 | |
| Domain | CH-domain | 1.06e-03 | 75 | 50 | 3 | IPR001715 | |
| Domain | ATPase_AAA_CS | 2.72e-03 | 29 | 50 | 2 | IPR003960 | |
| Domain | UBA | 2.91e-03 | 30 | 50 | 2 | SM00165 | |
| Domain | AAA | 3.73e-03 | 34 | 50 | 2 | PS00674 | |
| Domain | UBA | 4.18e-03 | 36 | 50 | 2 | PF00627 | |
| Domain | UBA | 6.18e-03 | 44 | 50 | 2 | IPR015940 | |
| Domain | AAA+_ATPase | 6.75e-03 | 144 | 50 | 3 | IPR003593 | |
| Domain | AAA | 6.75e-03 | 144 | 50 | 3 | SM00382 | |
| Domain | UBA | 7.03e-03 | 47 | 50 | 2 | PS50030 | |
| Domain | AAA | 8.55e-03 | 52 | 50 | 2 | PF00004 | |
| Domain | ATPase_AAA_core | 9.20e-03 | 54 | 50 | 2 | IPR003959 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 7689010 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 39269294 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10679933 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22001206 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 2.11e-06 | 2 | 51 | 2 | 24469451 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.76e-06 | 444 | 51 | 7 | 34795231 | |
| Pubmed | ATP5PB FLNA FLNC SYNE1 TMEM135 HKDC1 BSN YY1 THRAP3 PRRC2B MYBPC2 | 6.19e-06 | 1442 | 51 | 11 | 35575683 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15866709 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11252955 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12704190 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 29693275 | ||
| Pubmed | A prominent and conserved role for YY1 in Xist transcriptional activation. | 6.32e-06 | 3 | 51 | 2 | 25209548 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11038172 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11102480 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23608773 | ||
| Pubmed | Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm. | 6.32e-06 | 3 | 51 | 2 | 17825253 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27315375 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12393796 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16704418 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 9412467 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11153914 | ||
| Pubmed | Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family. | 6.32e-06 | 3 | 51 | 2 | 1429620 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 9.33e-06 | 719 | 51 | 8 | 35337019 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20554076 | ||
| Pubmed | Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. | 1.26e-05 | 4 | 51 | 2 | 20043068 | |
| Pubmed | A zonal organization of odorant receptor gene expression in the olfactory epithelium. | 1.26e-05 | 4 | 51 | 2 | 7683976 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 1.26e-05 | 4 | 51 | 2 | 22802962 | |
| Pubmed | DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk. | 1.26e-05 | 4 | 51 | 2 | 27614019 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.39e-05 | 1005 | 51 | 9 | 19615732 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 1.66e-05 | 558 | 51 | 7 | 27591049 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.77e-05 | 564 | 51 | 7 | 21565611 | |
| Pubmed | 1.86e-05 | 568 | 51 | 7 | 37774976 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 20534982 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 33296651 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 19366992 | ||
| Pubmed | Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. | 2.10e-05 | 5 | 51 | 2 | 23704821 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 12006559 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 17360453 | ||
| Pubmed | 2.90e-05 | 408 | 51 | 6 | 33766124 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 9006895 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 12679033 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 20843792 | ||
| Pubmed | Chromosomal localization and immunological analysis of a family of human 26S proteasomal ATPases. | 3.15e-05 | 6 | 51 | 2 | 9473509 | |
| Pubmed | 4.04e-05 | 45 | 51 | 3 | 18922472 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 26929074 | ||
| Pubmed | Structure of the human 26S proteasome at a resolution of 3.9 Å. | 4.41e-05 | 7 | 51 | 2 | 27342858 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 16076904 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ATP5PB VPS13D SYNE1 SEC24B TMEM135 PSMC1 PSMC3 NOL10 PRRC2B ALG13 | 5.36e-05 | 1496 | 51 | 10 | 32877691 |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 21628461 | ||
| Pubmed | Saturation mutagenesis defines novel mouse models of severe spine deformity. | 5.87e-05 | 8 | 51 | 2 | 34142127 | |
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 5.87e-05 | 8 | 51 | 2 | 17145501 | |
| Pubmed | HSPB7 prevents cardiac conduction system defect through maintaining intercalated disc integrity. | 5.87e-05 | 8 | 51 | 2 | 28827800 | |
| Pubmed | Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability. | 5.87e-05 | 8 | 51 | 2 | 22659184 | |
| Pubmed | Case-control genome-wide association study of attention-deficit/hyperactivity disorder. | 5.87e-05 | 8 | 51 | 2 | 20732627 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 20810900 | ||
| Pubmed | Comparative mapping of the actin-binding protein 280 genes in human and mouse. | 7.54e-05 | 9 | 51 | 2 | 8088838 | |
| Pubmed | Regulation of the anaphase-promoting complex by the COP9 signalosome. | 7.54e-05 | 9 | 51 | 2 | 19535905 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 11807098 | ||
| Pubmed | 8.35e-05 | 494 | 51 | 6 | 26831064 | ||
| Pubmed | 8.66e-05 | 58 | 51 | 3 | 19013454 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 19506036 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 15831487 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 9.56e-05 | 162 | 51 | 4 | 14743216 | |
| Pubmed | 1.06e-04 | 320 | 51 | 5 | 28685749 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 36579465 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 22275368 | ||
| Pubmed | 1.30e-04 | 334 | 51 | 5 | 30425250 | ||
| Pubmed | Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. | 1.33e-04 | 67 | 51 | 3 | 29863498 | |
| Pubmed | Mdm2 facilitates the association of p53 with the proteasome. | 1.38e-04 | 12 | 51 | 2 | 20479273 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.49e-04 | 1367 | 51 | 9 | 32687490 | |
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 1.63e-04 | 13 | 51 | 2 | 11014824 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.68e-04 | 807 | 51 | 7 | 22681889 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.68e-04 | 807 | 51 | 7 | 30575818 | |
| Pubmed | USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. | 1.72e-04 | 73 | 51 | 3 | 30224337 | |
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 7528109 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.03e-04 | 197 | 51 | 4 | 20811636 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 2.04e-04 | 1425 | 51 | 9 | 30948266 | |
| Pubmed | 2.07e-04 | 198 | 51 | 4 | 24337577 | ||
| Pubmed | 2.10e-04 | 1431 | 51 | 9 | 37142655 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 2.26e-04 | 847 | 51 | 7 | 35235311 | |
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 29979702 | ||
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 23903356 | ||
| Pubmed | 2.70e-04 | 85 | 51 | 3 | 15449545 | ||
| Pubmed | 2.78e-04 | 214 | 51 | 4 | 22199357 | ||
| Pubmed | 2.79e-04 | 1168 | 51 | 8 | 19946888 | ||
| Pubmed | 2.83e-04 | 215 | 51 | 4 | 35973513 | ||
| Pubmed | Different roles of Runx2 during early neural crest-derived bone and tooth development. | 2.83e-04 | 17 | 51 | 2 | 16813524 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 2.89e-04 | 87 | 51 | 3 | 17148452 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.18e-04 | 18 | 51 | 2 | 12119179 | |
| Pubmed | Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. | 3.18e-04 | 18 | 51 | 2 | 23575864 | |
| Pubmed | 3.40e-04 | 92 | 51 | 3 | 20301317 | ||
| Pubmed | Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development. | 3.55e-04 | 19 | 51 | 2 | 29374072 | |
| Pubmed | 3.55e-04 | 19 | 51 | 2 | 19490896 | ||
| Pubmed | 3.55e-04 | 19 | 51 | 2 | 23827681 | ||
| Pubmed | 3.55e-04 | 19 | 51 | 2 | 35941131 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 3.83e-04 | 233 | 51 | 4 | 32290105 | |
| Pubmed | Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. | 3.86e-04 | 96 | 51 | 3 | 34599178 | |
| Pubmed | 3.89e-04 | 657 | 51 | 6 | 36180527 | ||
| Pubmed | 3.89e-04 | 234 | 51 | 4 | 36243803 | ||
| Interaction | CARD8 interactions | 1.48e-05 | 60 | 50 | 4 | int:CARD8 | |
| Interaction | R3HDM2 interactions | 1.67e-05 | 129 | 50 | 5 | int:R3HDM2 | |
| Interaction | NPHP4 interactions | 2.50e-05 | 236 | 50 | 6 | int:NPHP4 | |
| GeneFamily | CD molecules|DASH family | 5.56e-05 | 7 | 30 | 2 | 1205 | |
| GeneFamily | Proteasome | 2.30e-03 | 43 | 30 | 2 | 690 | |
| GeneFamily | AAA ATPases | 3.48e-03 | 53 | 30 | 2 | 413 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.34e-03 | 66 | 30 | 2 | 722 | |
| GeneFamily | Olfactory receptors, family 2 | 1.50e-02 | 113 | 30 | 2 | 149 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN | 1.09e-05 | 150 | 51 | 5 | M6749 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP | 4.24e-05 | 199 | 51 | 5 | M9366 | |
| Coexpression | GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN | 4.35e-05 | 200 | 51 | 5 | M8384 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP | 4.35e-05 | 200 | 51 | 5 | M5711 | |
| Coexpression | MANALO_HYPOXIA_UP | 4.89e-05 | 205 | 51 | 5 | M259 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 174 | 51 | 5 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.98e-06 | 196 | 51 | 5 | d5f9168001e60bafec17fe6c702e68f5528edc20 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-06 | 200 | 51 | 5 | ac5843142e0f8a5bcd2c3a784ea13b2f955a32fd | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.12e-05 | 142 | 51 | 4 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.81e-05 | 165 | 51 | 4 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.81e-05 | 165 | 51 | 4 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.18e-05 | 169 | 51 | 4 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-05 | 172 | 51 | 4 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 178 | 51 | 4 | e5e5f5b4a27e120a1076b1cb250fa25d0c336956 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 178 | 51 | 4 | c661246269ce26c4fc62e12f86c5f90a2dcfdce0 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.59e-05 | 190 | 51 | 4 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.29e-05 | 195 | 51 | 4 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.29e-05 | 195 | 51 | 4 | febe746099964b9ea9e75f2efc72c962c01f0421 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.44e-05 | 196 | 51 | 4 | 8e909c31733762646359fe78b645cbd60237459e | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.58e-05 | 197 | 51 | 4 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-05 | 198 | 51 | 4 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 199 | 51 | 4 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-05 | 199 | 51 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 199 | 51 | 4 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | BAL-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 3.60e-04 | 121 | 51 | 3 | b49b044a687a31883dfccecf10a183b5ba567f7a | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.60e-04 | 121 | 51 | 3 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.60e-04 | 121 | 51 | 3 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 127 | 51 | 3 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.34e-04 | 129 | 51 | 3 | 856255fbfc7f95642000cfd7704141b2388f7c5c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.62e-04 | 141 | 51 | 3 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-04 | 143 | 51 | 3 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-3|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.22e-04 | 146 | 51 | 3 | e55b4acecf4e363b5afa287c747c2e58c4597f3a | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 6.34e-04 | 147 | 51 | 3 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.60e-04 | 149 | 51 | 3 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 150 | 51 | 3 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 6.99e-04 | 152 | 51 | 3 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-04 | 153 | 51 | 3 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.26e-04 | 154 | 51 | 3 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.96e-04 | 159 | 51 | 3 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-04 | 159 | 51 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, Lineage and Cell Type | 8.26e-04 | 161 | 51 | 3 | 9fb73909fc2ec99f96ca2eed1a053bce89de7d16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.26e-04 | 161 | 51 | 3 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 8.71e-04 | 164 | 51 | 3 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.71e-04 | 164 | 51 | 3 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | control-Plasmablast|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.86e-04 | 165 | 51 | 3 | 61063e0ce61bc92d5d1093be8279af03f650720b | |
| ToppCell | Tuft-tuft-1|World / Class top | 9.34e-04 | 168 | 51 | 3 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 9.34e-04 | 168 | 51 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.34e-04 | 168 | 51 | 3 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-04 | 168 | 51 | 3 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | d2862a7ddee6d7a65d84ef9d0800ba6f4690973f | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.50e-04 | 169 | 51 | 3 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | 8dba7546adc6b1345933eec81fc77fc9611fae60 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.66e-04 | 170 | 51 | 3 | fed8e982d2ce234c59d4016432ed8941df36df27 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.83e-04 | 171 | 51 | 3 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.83e-04 | 171 | 51 | 3 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.83e-04 | 171 | 51 | 3 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.83e-04 | 171 | 51 | 3 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 9.99e-04 | 172 | 51 | 3 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.99e-04 | 172 | 51 | 3 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 173 | 51 | 3 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 173 | 51 | 3 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 173 | 51 | 3 | 176d7dc103b8161c4e2d7dc74f2dc77ea1f2d2ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 173 | 51 | 3 | 3001dd39244ef0a5a475d569a78f4ae427a55db6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 173 | 51 | 3 | c88883fb2a33e21d4201aa393674aa3f2ad780c9 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 173 | 51 | 3 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 173 | 51 | 3 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 174 | 51 | 3 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-03 | 174 | 51 | 3 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 174 | 51 | 3 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-03 | 175 | 51 | 3 | c6c0196875f3b5293083cda6718300806a801941 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-03 | 175 | 51 | 3 | 82c4d1edaa0d3b82d3ef4676d6f6516104a2656a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-03 | 175 | 51 | 3 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.07e-03 | 176 | 51 | 3 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-03 | 177 | 51 | 3 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-03 | 177 | 51 | 3 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-03 | 177 | 51 | 3 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-03 | 177 | 51 | 3 | 599cf7f5b774e197a1b43c98e4b9a8c1a618f38a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-03 | 177 | 51 | 3 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-03 | 177 | 51 | 3 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-03 | 177 | 51 | 3 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-03 | 178 | 51 | 3 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-03 | 178 | 51 | 3 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 1.10e-03 | 178 | 51 | 3 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 178 | 51 | 3 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 1.10e-03 | 178 | 51 | 3 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-03 | 178 | 51 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-03 | 178 | 51 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-03 | 178 | 51 | 3 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-03 | 178 | 51 | 3 | 87b04753650e45f12299c8456fb980d6c0d5961c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-03 | 178 | 51 | 3 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-03 | 178 | 51 | 3 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-03 | 178 | 51 | 3 | ebfae386a518ea33911ba3ff40464c94d18ef695 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-03 | 178 | 51 | 3 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.12e-03 | 179 | 51 | 3 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-03 | 179 | 51 | 3 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.12e-03 | 179 | 51 | 3 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| Drug | C5-substituted pyrrolidine 31 | 4.92e-06 | 2 | 51 | 2 | CID010339570 | |
| Drug | SureCN3749646 | 1.47e-05 | 3 | 51 | 2 | CID011530920 | |
| Drug | SureCN3745540 | 1.47e-05 | 3 | 51 | 2 | CID011974437 | |
| Drug | SureCN3749947 | 1.47e-05 | 3 | 51 | 2 | CID011974435 | |
| Drug | ABT-279 | 1.47e-05 | 3 | 51 | 2 | CID016049769 | |
| Drug | Cyanopyrrolidine 38 | 1.47e-05 | 3 | 51 | 2 | CID010932707 | |
| Drug | Cyanopyrrolidine 39 | 1.47e-05 | 3 | 51 | 2 | CID011117606 | |
| Drug | SureCN3748611 | 1.47e-05 | 3 | 51 | 2 | CID011974325 | |
| Drug | Diprolyl-alanine | 1.47e-05 | 3 | 51 | 2 | CID000193559 | |
| Drug | glycylproline 4-nitroanilide | 2.94e-05 | 4 | 51 | 2 | ctd:C042892 | |
| Drug | AC1NRATE | 3.60e-05 | 83 | 51 | 4 | CID005288086 | |
| Drug | prodipine | 4.90e-05 | 5 | 51 | 2 | CID000065775 | |
| Drug | 1-N-methyl-5-thiotetrazole | 4.90e-05 | 5 | 51 | 2 | ctd:C038625 | |
| Drug | arginyl(PMC)-pyrrolidine-2-nitrile | 4.90e-05 | 5 | 51 | 2 | CID000487437 | |
| Drug | alanylproline-4-nitroanilide | 4.90e-05 | 5 | 51 | 2 | ctd:C083013 | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; HL60; HG-U133A | 7.11e-05 | 193 | 51 | 5 | 1375_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 7.11e-05 | 193 | 51 | 5 | 3098_DN | |
| Drug | cathepsin C substrate | 7.34e-05 | 6 | 51 | 2 | CID003508173 | |
| Drug | NVP-DPP728 | 7.34e-05 | 6 | 51 | 2 | CID009796290 | |
| Drug | MK-251 | 7.34e-05 | 6 | 51 | 2 | CID000176160 | |
| Drug | Cefoperazone | 7.34e-05 | 6 | 51 | 2 | ctd:D002438 | |
| Drug | II 19 | 7.34e-05 | 6 | 51 | 2 | CID000040321 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 7184_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 1505_UP | |
| Drug | Compound 10 | 7.80e-05 | 37 | 51 | 3 | CID003749170 | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2773_UP | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 7202_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 3078_DN | |
| Drug | Epostatin | 1.03e-04 | 7 | 51 | 2 | CID006449105 | |
| Drug | o-Py | 1.03e-04 | 7 | 51 | 2 | CID009942336 | |
| Drug | CID6451162 | 1.37e-04 | 8 | 51 | 2 | CID006451162 | |
| Drug | acronycine | 1.37e-04 | 8 | 51 | 2 | CID000345512 | |
| Drug | P32/98 | 1.37e-04 | 8 | 51 | 2 | CID006918464 | |
| Drug | imidazolelactate | 1.37e-04 | 8 | 51 | 2 | CID000000793 | |
| Drug | Gly-D-Phe | 1.50e-04 | 46 | 51 | 3 | CID000092953 | |
| Drug | NSC-334212 | 1.75e-04 | 9 | 51 | 2 | CID000333414 | |
| Drug | Gly-pro-na | 1.75e-04 | 9 | 51 | 2 | CID000194319 | |
| Drug | Appna | 1.75e-04 | 9 | 51 | 2 | CID006453929 | |
| Drug | Phe-pro-ala | 1.75e-04 | 9 | 51 | 2 | CID000133668 | |
| Drug | SureCN475872 | 1.75e-04 | 9 | 51 | 2 | CID011163584 | |
| Drug | NSC285223 | 2.19e-04 | 10 | 51 | 2 | CID000323607 | |
| Drug | N-phenylphthalimide | 2.19e-04 | 10 | 51 | 2 | CID000068215 | |
| Drug | Hxp | 2.19e-04 | 10 | 51 | 2 | CID000449159 | |
| Drug | X1043 | 2.19e-04 | 10 | 51 | 2 | CID011235728 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 6.64e-05 | 48 | 48 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | transitional cell carcinoma (is_implicated_in) | 5.86e-04 | 22 | 48 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | Epileptic encephalopathy | 1.09e-03 | 30 | 48 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYYLEMLIGTPPQKL | 91 | Q9Y5Z0 | |
| NAKPNKVYMGPGQLY | 736 | O15013 | |
| MGKDYYKILGIPSGA | 1 | O75953 | |
| KGRGYQKMPGGYVPE | 561 | Q9NP73 | |
| GQKGYVPANYLGKMT | 761 | Q9NXL2 | |
| PGYGTMGKPIKLLAN | 21 | Q9H9G7 | |
| YLVPGMTYSKGKIYP | 306 | Q15517 | |
| YGVKTGTQPPGKMEY | 471 | Q9Y2E6 | |
| LGVMVYGIKKYGPFV | 106 | P24539 | |
| YSKILGPKPQGVYMG | 441 | Q8NHS3 | |
| KMIPGYPQAKLYPGK | 141 | Q9NW15 | |
| MPKKGQPGYPSSAEY | 3691 | Q9UPA5 | |
| GGIHPVRYQPGKYPM | 76 | Q9NRQ2 | |
| MAPGNYLIAIKYGGP | 2566 | Q14315 | |
| EYKGMPGGRNLYKIQ | 421 | P27487 | |
| GIFPDIYKMYNGSVP | 331 | P22413 | |
| NETPKMGIYYIPVLG | 331 | Q9BSC4 | |
| IMYVGPRYGNPKEQK | 256 | Q96R45 | |
| YKEVMKQYGLGPNGG | 76 | Q9HCN4 | |
| IMYVGPRYGNPKEQK | 256 | O95047 | |
| LGPKMYNAYGLITPE | 1096 | Q9Y4C1 | |
| GEKYGYLSLPKPMKN | 531 | Q9UBT7 | |
| LYGMIYKPHALQPGK | 621 | Q86TI2 | |
| AYGPGIEPTGNMVKK | 286 | P21333 | |
| AGYAPVKYIQPMQKG | 36 | P25067 | |
| TTMLGGYFYIPPVNK | 86 | P11245 | |
| CPPKGNMPKGYVYLV | 351 | Q9BZB8 | |
| GLLLYLKTGQMYPVP | 331 | P51530 | |
| QPSKMAKPFGYGYPT | 451 | O95487 | |
| VGHLYGPYGKELPAM | 181 | O60422 | |
| DKYGQPLPGYTTKGK | 266 | P17936 | |
| PKDKPRYLMGVGYAT | 251 | Q9BXR0 | |
| PTGPELDTSYKGYMK | 8361 | Q8NF91 | |
| GMDGTLYKIHPQYPK | 411 | Q2TB90 | |
| YEEMGIKPPKGVILY | 211 | P62191 | |
| GTAKKNGGTLYYMAP | 181 | Q13546 | |
| PGMKPYGYKECGKGL | 201 | P17025 | |
| MKSPREPGYKAEGKY | 696 | Q9Y2W1 | |
| KGYGLMKIDEPSPPY | 61 | Q6NXS1 | |
| KGVLMYGPPGTGKTL | 221 | P17980 | |
| YSEYMTGKKLPPGGI | 251 | P25490 | |
| MYFKGIEAGKVPYFP | 361 | Q86UB9 | |
| PEGYMALQSKGYPLP | 746 | Q5JSZ5 | |
| LGVAYPKGMYDVGLP | 116 | Q16222 | |
| LEYSEYMTGKKLPPG | 141 | Q96MM3 | |
| IYGLPTGEYPGLMKV | 256 | Q9P0Z9 | |
| IPGGPHLMLYDYKQG | 71 | Q9NWC5 | |
| QESGTKLKPMYGPGY | 321 | Q92995 | |
| KLKPMYGPGYTGLKN | 326 | Q92995 | |
| FYVKGMPINGTLKPG | 3196 | Q5THJ4 | |
| PPMYDGGKPVTGYLV | 661 | Q14324 | |
| VYIGMLGEPKYVKTP | 406 | Q9Y2G1 |